Pharmacology Biochemistry and Behavior logo Elsevier logo

Publisher: Elsevier

Related content
Volume 73, Number 2, September 2002

< previous issue | all issues | next issue >

Metabotropic glutamate receptors
pp. 285-286(2)
Authors: Schoepp, D.D.; Merck & Company, I.

Neuronal and glial mGluR5 modulation prevents stretch-induced enhancement of NMDA receptor current
pp. 287-298(12)
Authors: Lea, P.M.; Custer, S.J.; Vicini, S.; Faden, A.I.

NMDA-induced phosphorylation and regulation of mGluR5
pp. 299-306(8)
Authors: Alagarsamy, S.; Rouse, S.T.; Junge, C.; Hubert, G.W.; Gutman, D.; Smith, Y.; Conn, P.J.

Modulation of DOI-induced increases in cortical BDNF expression by group II mGlu receptors
pp. 317-326(10)
Authors: Gewirtz1, J.C.; Chen, A.C.; Terwilliger, R.; Duman, R.C.; Marek, G.J.

Group II mGlu receptor agonists inhibit behavioural and electrophysiological effects of DOI in mice
pp. 327-332(6)
Authors: Klodzinska, A.; Bijak, M.; Tokarski, K.; Pilc, A.

Effects of the mGlu2/3 receptor agonist LY379268 on motor activity in phencyclidine-sensitized rats
pp. 339-346(8)
Authors: Clark1, M.; Johnson, B.G.; Wright, R.A.; Monn, J.A.; Schoepp, D.D.

Anxiolytic-like activity of the mGluR5 antagonist MPEP - A comparison with diazepam and buspirone
pp. 359-366(8)
Authors: Brodkin, J.; Busse, C.; Sukoff, S.J.; Varney, M.A.

Differential effects of mGluR1 and mGlur5 antagonism on spatial learning in rats
pp. 381-389(9)
Authors: Petersen, S.; Bomme, C.; Baastrup, C.; Kemp, A.; Christoffersen, G.R.J.

Impairment of contextual fear conditioning in rats by Group I mGluRs - Reversal by the nootropic nefiracetam
pp. 391-399(9)
Authors: Riedel, G.; Sandager-Nielsen1, K.; Macphail, E.M.

Antisense oligonucleotide knockdown of mGluR1 alleviates hyperalgesia and allodynia associated with chronic inflammation
pp. 401-410(10)
Authors: Fundytus, M.E.; Osborne, M.G.; Henry, J.L.; Coderre, T.J.; Dray, A.

Group II mGluR receptor agonists are effective in persistent and neuropathic pain models in rats
pp. 419-427(9)
Authors: Simmons, R.M.A.; Webster, A.A.; Kalra, A.B.; Iyengar, S.

Activation of mGlu1 but not mGlu5 metabotropic glutamate receptors contributes to postischemic neuronal injury in vitro and in vivo
pp. 439-446(8)
Authors: Meli, E.; Picca, R.; Attucci, S.; Cozzi, A.; Peruginelli, F.; Moroni, F.; Pellegrini-Giampietro, D.E.

Spinal cord mGlu1a receptors - Possible target for amyotrophic lateral sclerosis therapy
pp. 447-454(8)
Authors: Valerio, A.; Ferrario, M.; Paterlini1, M.; Liberini2, P.; Moretto, G.; Cairns, N.J.; Pizzi, M.; Spano, P.

Evaluation of the mGluR2/3 agonist LY379268 in rodent models of Parkinson's disease
pp. 455-466(12)
Authors: Murray, T.K.; Messenger, M.J.; Ward, M.A.; Woodhouse, S.; Osborne, D.J.; Duty, S.; O'Neill, M.J.

The selective group mGlu2/3 receptor agonist LY379268 suppresses REM sleep and fast EEG in the rat
pp. 467-474(8)
Authors: Feinberg, I.; Campbell, I.G.; Schoepp, D.D.; Anderson, K.

< previous issue | all issues | next issue >

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page